Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pexa-Vec + Socazolimab in Metastatic Melanoma
NCT04849260Phase 2Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Aug 2021
- Primary completion
- May 2022
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus in melanoma, sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT04849260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04849260.